RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.…
Upcoming Meeting Dates - September 28, 2026
RAMM Pharma (CNSX: RAMM) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.
The shares were at 0.0100 CAD on 19 November 2026, down 33.3% over 52 weeks. Its 52-week range is 0.0050 CAD to 0.2500 CAD: the price is 96.0% below the high and 100.0% above the low.
Its market capitalisation is 1.19M CAD.
RAMM Pharma reports return on equity of -156.4%, an operating margin of -335.1% and revenue down 70.6% year over year.
Its debt exceeds its cash by 22.42K CAD, a debt-to-equity ratio of 0.01. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.
No upcoming events tracked.